Poly-γ-D-glutamic acid capsule interferes with lytic infection of Bacillus anthracis by B. anthracis-specific bacteriophages

Applied and Environmental Microbiology

Volumn 79, Issue 2, 2013, Pages 714-717

  Negus, David ^a   Burton, Jane ^b   Sweed, Angela ^b   Gryko, Romuald ^c   Taylor, Peter ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c MILITARY INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BACILLUS ANTHRACIS; OUTER LAYER;

AMINO ACIDS; BACTERIA;

BACTERIOPHAGES;

HYDROLASE; POLYGLUTAMIC ACID; VIRUS DNA;

AMINO ACID; BACTERIAL DISEASE; BACTERIOPHAGE; FACILITATION; GENE EXPRESSION; INHIBITION;

ARTICLE; BACILLUS ANTHRACIS; BACILLUS PHAGE; BACTERIAL CAPSULE; BACTERIOLYSIS; CHEMISTRY; DNA SEQUENCE; ENZYMOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; VIROLOGY;

BACILLUS ANTHRACIS; BACILLUS PHAGES; BACTERIAL CAPSULES; BACTERIOLYSIS; DNA, VIRAL; HYDROLASES; MOLECULAR SEQUENCE DATA; POLYGLUTAMIC ACID; SEQUENCE ANALYSIS, DNA;

BACILLUS ANTHRACIS;

EID: 84871898104     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.02682-12     Document Type: Article

References (24)

1. Koehler TM. 2002. Bacillus anthracis genetics and virulence gene regulation. Curr. Top. Microbiol. Immunol. 271:143-164.
2. Mock M, Fouet A. 2001. Anthrax. Annu. Rev. Microbiol. 55:647-671.
3. Franz DR, Jahrling PB, Friedlander AM, McClain DJ, Hoover DL, Bryne WR, Pavlin JA, Christopher GW, Eitzen EM. 1997. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 278:399-411.
4. Brook I, Elliott TB, Pryor HI, Sautter TE, Gnade BT, Thakar JH, Knudson GB. 2001. In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolones. Int. J. Antimicrob. Agents 18: 559-562.
5. Price LB, Vogler A, Pearson T, Busch JD, Schupp JM, Keim P. 2003. In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin. Antimicrob. Agents Chemother. 47: 2362-2365.
6. Kim HS, Choi EC, Kim BK. 1993. A macrolide-lincosamidestreptogramin B resistance determinant from Bacillus anthracis 590: cloning and expression of ermJ. J. Gen. Microbiol. 139:601-607.
7. Inal JM. 2003. Phage therapy: a reappraisal of bacteriophages as antibiotics. Arch. Immunol. Ther. Exp. 51:237-244.
8. Walter MH. 2003. Efficacy and durability of bacteriophages used against spores. J. Environ. Health 66:9-15.
9. Scorpio A, Chabot DJ, Day WA, O'Brien DK, Vietri NJ, Itoh Y, Mohamadzadeh M, Friedlander AM. 2007. Poly-gamma-glutamate capsule-degrading enzyme treatment enhances phagocytosis and killing of encapsulated Bacillus anthracis. Antimicrob. Agents Chemother. 51:215-222.
10. Sutherland IW, Hughes KA, Skillman LC, Tait K. 2004. The interaction of phage and biofilms. FEMS Microbiol. Lett. 232:1-6.
11. Mushtaq N, Redpath MB, Luzio JP, Taylor PW. 2004. Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype. Antimicrob. Agents Chemother. 48:1503-1508.
12. Kimura K, Itoh Y. 2003. Characterization of poly-gamma-glutamate hydrolase encoded by a bacteriophage genome: possible role in phage infection of Bacillus subtilis encapsulated with poly-gamma-glutamate. Appl. Environ. Microbiol. 69:2491-2497.
13. Abshire TG, Brown JE, Ezzell JW. 2005. Production and validation of the use of gamma phage for identification of Bacillus anthracis. J. Clin. Microbiol. 43:4780-4788.
14. Davison S, Couture-Tosi E, Candela T, Mock M, Fouet A. 2005. Identification of the Bacillus anthracis (gamma) phage receptor. J. Bacteriol. 187:6742-6749.
15. Brown ER, Moody MD, Treece EL, Smith CW. 1958. Differential diagnosis of Bacillus cereus, Bacillus anthracis, and Bacillus cereus var. mycoides. J. Bacteriol. 75:499-509.
16. McCloy EW. 1951. Studies on a lysogenic Bacillus strain. I. A bacteriophage specific for Bacillus anthracis. J. Hyg. (Lond.) 49:114-125.
17. McCloy EW. 1951. Unusual behaviour of a lysogenic Bacillus strain. J. Gen. Microbiol. 5:xiv-xv.
18. Brown ER, Cherry WB. 1955. Specific identification of Bacillus anthracis by means of a variant bacteriophage. J. Infect. Dis. 96:34-39.
19. Minakhin L, Semenova E, Kiu J, Vasilov A, Severinova E, Gabisonia T, Inman R, Mushegian A, Severinov K. 2005. Genome sequence and gene expression of Bacillus anthracis bacteriophage Fah. J. Mol. Biol. 354:1-15.
20. Vidaver AK. 1967. Synthetic and complex media for the rapid detection of fluorescence of phytopathogenic pseudomonads: effect of the carbon source. Appl. Microbiol. 15:1523-1524.
21. Thorne CB, Gómez CG, Housewright RD. 1952. Synthesis of glutamic acid and glutamyl polypeptide by Bacillus anthracis. II. The effect of carbon dioxide on peptide production on solid media. J. Bacteriol. 63:363-368.
22. Tomlinson S, Taylor PW. 1985. Neuraminidase associated with coliphage E that specifically depolymerizes the Escherichia coli K1 capsular polysaccharide. J. Virol. 55:374-378.
23. Schuch R, Fischetti VA. 2006. Detailed genomic analysis of theWβ and γ phages infecting Bacillus anthracis: implications for evolution of environmental fitness and antibiotic resistance. J. Bacteriol. 188:3037-3051.
24. Candela T, Fouet A. 2005. Bacillus anthracis CapD, belonging to the γ-glutamyltranspeptidase family, is required for the covalent anchoring of capsule to peptidoglycan. Mol. Microbiol. 57:717-726.